Microbiome and Host Susceptibility in Severe Pneumonia, a Prospective, Multicenter, Cohort Study

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorFirst Affiliated Hospital of Zhejiang University

About this trial

This study was a prospective multicenter cohort of severe pneumonia. And by collecting clinical samples to clarify the correlation between lung microbiome, intestinal microbiome, host susceptibility, and prognosis of severe pneumonia patients.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

Expected length of stay in ICU is less than 1 day

Pregnant

Trial population

Overall, the investigators will include all severe pneumonia patients transferred to the ICU, including community acquired pneumonia, hospital acquired pneumonia, and ventilator-associated pneumonia.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Metagenomics

    Diagnostic test

    Clinical metagenomics is used to evaluate pathogens

Treatment groups

2,000 Participants
are divided into 1 treatment group
Group A: Severe pneumonia1 intervention

Trial outcomes

Primary outcomes

1

The correlation between lung microbiome and disease prognosis

1\. Identification of microbial gene profiles; 2. Analysis of host health dynamics and trends; 3. Identification of host gene mutations; 4. Preliminary model construction; 5. Model optimization and evaluation.

Time frame
60 days

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.